Paloma Partners’s InflaRx IFRX Stock Holding History

Paloma Partners’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,453	Closed	-$526K	–	1796
2018 Q4	$526K	Buy	+14,453	New	+$445K	0.02%	655

Other funds holding IFRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Paloma Partners's IFRX Position: Q1 2019 in Review

Paloma Partners sold out of InflaRx (IFRX) in Q1 2019, closing a stake of 14,453 shares — an estimated $526K sold.

Paloma Partners first reported a position in IFRX in Q4 2018 and held it in 1 quarter. The position peaked at $526K in Q4 2018. 46 funds tracked by Wall St. Rank hold IFRX as of Q1 2019.

Paloma Partners reported no remaining InflaRx position as of Q1 2019 after selling out during the quarter.
Paloma Partners sold 14,453 InflaRx shares in Q1 2019, an estimated $526K.
Paloma Partners first reported a position in InflaRx in Q4 2018 and held it in 1 quarter.
Paloma Partners's InflaRx position peaked at $526K in Q4 2018.
46 funds tracked by Wall St. Rank held InflaRx as of Q1 2019.

Based on Paloma Partners's 13F filing for Q1 2019, filed 15 May 2019.